We are thrilled to announce the collaboration between the Follicular Lymphoma Foundation (FLF) and the Leukemia & Lymphoma Society (LLS), as we embark on our inaugural shared programme to combat follicular lymphoma (FL). Building upon our proud partnership announcement with LLS on August 7th 2023, we are ready to begin the process for the second cycle of the CURE FL Awards, known as the “LLS-FLF Research United to CURE FL Awards”. This strategic alliance aims to further accelerate pioneering research, building on the remarkable success of the initial cycle of our CURE FL Awards programme, and charting a path towards eliminating FL while inspiring hope among patients and their families.
How will this programme benefit patients?
For patients who may be wondering what the CURE FL Awards entail and how they can benefit from this initiative, please visit our dedicated page for more information: CURE FL Awards Programme. This programme is a unique research grant initiative designed to catalyse scientific research, leading to better treatments and cures for follicular lymphoma. It brings together top clinical scientists and researchers from around the world to pursue the most innovative and exciting FL research projects. We hope that the progress made by our leading investigative teams will bring us closer to clinical trials and successful outcomes for patients as soon as possible
Empowering through research grants
Through the LLS-FLF Research United to CURE FL Awards, FLF and LLS intend to co-fund up to four research grants with a total of up to $3.5m, within the LLS Translational Research Programme (TRP) (up to $750,000 over 3 years per grant), or the LLS Academic Clinical Trials (ACT) programme (up to $1 million over 2-3 years per grant).
These research grants are an opportunity for PhD and MD-level investigators to drive forward transformative research, regardless of prior experience specifically in FL. The initiative encourages novel ideas and fresh perspectives to take centre stage.
Dr Mitchell Smith, CMO of the FLF said:
As Chief Medical Officer of the FLF, I am thrilled to see the continuation of the CURE FL Awards through Cycle 2. By united efforts with LLS, we have the power to drive transformative research and bring us closer to our goal of finding curative therapies for FL.
Catalysing curative research
The heart of the initiative is the request for proposals designed to fuel innovative research projects that hold the potential to cure FL at first relapse. Researchers, scientists, and investigators are invited to submit proposals for projects focusing on immune system-engaging therapies, including cellular immunotherapy (CAR-T and others) and humoral approaches (bispecific molecules), as well as targeted therapy for FL. See details below.
The long-term goal is to pave the way for rational sequencing of these therapeutic strategies, ultimately leading to curative outcomes for a larger fraction of FL patients. By investing in cutting-edge research and exploration, the initiative aims to address the high unmet needs of the FL patient population.
Transforming lives through research
FLF and LLS recognise that improving the lives of FL patients and their experiences are at the core of their mission. Alongside the rigorous scientific peer review process, all research proposals will undergo review by a dedicated Patient Review Panel. Patient insights and perspectives are crucial in shaping research directions that hold the most promise for impactful therapeutic development.
About The Follicular Lymphoma Foundation
The Follicular Lymphoma Foundation (FLF) is a global organisation committed to advancing research, raising awareness, and providing support for those affected by Follicular Lymphoma. Established in 2019, FLF is dedicated to accelerating the discovery of new treatments and potential cures for this complex disease.
For further information, visit theflf.org/news. Follow us on Facebook, LinkedIn, and Instagram.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. LLS funds lifesaving blood cancer research around the world, provides free information and support services.
For additional information, visit lls.org/lls-newsnetwork. Follow them on Facebook, Twitter, and Instagram.
This announcement was made on August 22, 2023, and represents the collaborative efforts of the Follicular Lymphoma Foundation and the Leukemia & Lymphoma Society.
